The future of healthcare is being shaped by rapid and accurate diagnostics, and the Point-of-Care Molecular Diagnostics Market is leading the charge. This market is poised for significant growth, with a projected value of USD 11.1 billion by 2033. Starting from a valuation of USD 4.4 billion in 2023, the market is expected to expand …
Tag Archives: Point-Of-Care Molecular Diagnostics
Point of Care Molecular Diagnostics Market Set to Surge at 9.7% CAGR, Reaching US$11.1 Billion by 2033 | FMI Study
The Point of Care Molecular Diagnostics Market is poised for a remarkable expansion, fueled by the increasing demand for rapid and accurate diagnoses at the patient’s bedside. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to skyrocket from a valuation of US$4.4 billion in …
Global Point of Care Molecular Diagnostics Industry Aiming for a Striking US$ 11.1 Billion Market by 2033, Fueled by a CAGR of 9.7%
The Global Point of Care Molecular Diagnostics Industry is positioned for unprecedented expansion, according to the latest forecast by Future Market Insights (FMI). With a projected valuation of US$ 4.4 billion in 2023, this dynamic industry is on track to reach an impressive US$ 11.1 billion by 2033, reflecting a robust Compound Annual Growth Rate …
Global Point of care Molecular Diagnostics Industry Set for Remarkable Growth, Expected to Reach US$ 11.1 Billion by 2033 | FMI
The Global Point Of Care Molecular Diagnostics Industry is on the brink of substantial expansion, with a projected valuation of US$ 4.4 billion in 2023, and it is poised to soar to US$ 11.1 billion by 2033, demonstrating a robust Compound Annual Growth Rate (CAGR) of 9.7% throughout the forecast period. This exciting trajectory reflects …
Precision Medicine’s Cornerstone: Point-Of-Care Molecular Diagnostics to Exhibit 9.7% CAGR, Reaching US$11.1 Billion by 2033
The Point-Of-Care Molecular Diagnostics Market is predicted to secure a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …